U.S. based developer of diagnostic & therapeutics establishes KSL Biomedical Canada, Inc., seeks to actively build leadership team to...

Leadership identified strong synergies between genomic and diagnostic immunology labs.

KSL has developed diagnostic tests and is moving forward with clinical validation of prognostic tools that could improve patient care...

PredictImmune and US partner KSL Diagnostics are pleased to announce they will be attending the Crohn’s & Colitis Congress® ...

Exclusive deal with KSL Biomedical signals PredictImmune’s major move into North America Cambridge, UK — PredictImmune, developers of...

JIANGSU, CHINA — As its first step to establish operations in China, KSL Biomedical has built 450 square meters of administrative and...